No significant association of type 2 diabetes‐related genetic risk scores with glycated haemoglobin levels after initiating metformin or sulphonylurea derivatives

AIM: To explore the added value of diabetes‐related genetic risk scores (GRSs) to readily available clinical variables in the prediction of glycated haemoglobin (HbA1c) levels after initiation of glucose‐regulating drugs. MATERIALS AND METHODS: We conducted a cohort study in people with type 2 diabe...

Descripción completa

Detalles Bibliográficos
Autores principales: Martono, Doti P., Heerspink, Hiddo J.L., Hak, Eelko, Denig, Petra, Wilffert, Bob
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6772120/
https://www.ncbi.nlm.nih.gov/pubmed/31168905
http://dx.doi.org/10.1111/dom.13803

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6772120/
https://www.ncbi.nlm.nih.gov/pubmed/31168905
http://dx.doi.org/10.1111/dom.13803

Ejemplares similares